COSM
HEALTHCARECosmos Health Inc
$0.35-0.00 (-0.85%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving COSM Today?
No stock-specific AI insight has been generated for COSM yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$0.28$1.32
$0.35
Fundamentals
Market Cap$18M
P/E Ratio—
EPS$-0.63
Dividend Yield—
Dividend / Share—
ROE-0.9%
Profit Margin-0.3%
Debt / Equity—
Trading
Volume437K
Avg Volume (10D)—
Shares Outstanding52.3M
COSM News
20 articles- Cosmos Health Receives Updated Zacks Research Report: 2026 Revenue Forecast Raised to $103.2 Million, EPS Outlook Upgraded to Positive Territory, and $4.50 Valuation ReaffirmedYahoo Finance·May 8, 2026
- COSM Introduces New Product for Sexual HealthYahoo Finance·May 6, 2026
- Cosmos Health Introduces Fort18 in the United States - A Men's Sexual Stamina Supplement Expanding the 18 Series into Men's WellnessYahoo Finance·May 6, 2026
- Cosmos Health Projects Over $2.5 Million in Incremental Annual Revenue from Cur18 in the United States Within 12-18 MonthsYahoo Finance·Apr 30, 2026
- COSM Launches US Products with Huge Market PotentialYahoo Finance·Apr 22, 2026
- Cosmos Health Introduces the "18 Series" in the United States - A Science-Driven Nutraceutical Platform Built on Patented Ingredients, Published Clinical Research, and Exact Clinical Dosing; Targeting a Portfolio of 18 Clinically Validated ProductsYahoo Finance·Apr 21, 2026
- Cosmos Health Accelerates U.S. Expansion: Liv18 Phase 1 Execution Complete; Production and Sales Commencing April 2026; Expected to Generate $5M+ in Annual Revenue at ~75% Gross Margins; Early U.S. Commercial Traction Observed Across Product PortfolioYahoo Finance·Apr 20, 2026
- Cosmos Health Continues US Expansion with Q2 Launch of Cur18 - a Clinically Studied, Patented Curcumin Next-Gen Therapy Supplement Delivering 39× Higher Bioavailability and Designed to Support Joint HealthYahoo Finance·Apr 17, 2026
- Cosmos Health Advances AI Investments to Enhance Efficiency, Reduce Costs, Improve Customer Experience and Drive Sales Growth; Certain Operating Expenses May Decrease by Up to 30%Yahoo Finance·Apr 16, 2026
- COSM Earnings Show Rapid Revenue GrowthYahoo Finance·Apr 16, 2026
- Cosmos Health Reports Full Year 2025 Results: Revenue Hits All-Time Record of $65.3M, Up 20%; Gross Profit Surges 83% to $7.9M; Gross Margin Expands 418 Basis Points; Adjusted EPS Improves 82%; Cash Position Up 10x to $3.5M; Record Growth Continues Into 2026 Across All Core SegmentsYahoo Finance·Apr 15, 2026
- Cosmos Health Receives Third Consecutive Purchase Order from Pharmalink for 60,000 Units of Sky Premium Life Products in the UAE; Cumulative Orders Reach 270,000 Units, Advancing 5-Year Goal of Over 3 million UnitsYahoo Finance·Apr 13, 2026
- Cosmos Health Reports No Impact from Iran and Middle East Conflict; Revenue Continues at All-Time High Levels; NOOR U.S. Expansion on Track to Exceed $12 Million Within 12 MonthsYahoo Finance·Apr 10, 2026
- COSM Announces Liver Health Product with Large Upside PotentialYahoo Finance·Apr 9, 2026
- Cosmos Health Continues Expansion in the United States with Q2 Launch of Liv18 - a Clinically Proven, Patented Supplement for Liver Fat ReductionYahoo Finance·Apr 8, 2026
- COSM Makes Investments That Further Highlight Growth ProspectsYahoo Finance·Apr 2, 2026
- Cosmos Health Announces Successful EN 12791 Study Results for C-Scrub Wash 4%, Strengthening Expansion into Hospital and Surgical MarketsYahoo Finance·Apr 1, 2026
- Cosmos Health Provides Update; Evaluates Options to Address Valuation Disconnect; Will Issue Updated Guidance Following FY 2025 Results; Record Growth Continues as Significant U.S. Expansion Underway, with Additional $12M+ in High-Margin Revenue Projected; Important R&D Updates Expected Following Finalization of Certain Anticipated TransactionsYahoo Finance·Mar 19, 2026
- Cosmos Health Enters into LOI to Acquire $11,500,000 Pharmacy Distribution Network; Remains on Track to Deliver 2027 Revenue Guidance of $155,800,000Yahoo Finance·Mar 10, 2026
- Cosmos Health Appoints Globally Recognized AI-Driven Drug Discovery and Clinical-Stage Biotech Expert Dr. Dimitrios Iliopoulos to Advisory BoardYahoo Finance·Feb 24, 2026
All 20 articles loaded
Price Data
Open$0.35
Previous Close$0.36
Day High$0.37
Day Low$0.35
52 Week High$1.32
52 Week Low$0.28
52-Week Range
$0.28$1.32
$0.35
Fundamentals
Market Cap$18M
P/E Ratio—
EPS$-0.63
Dividend Yield—
Dividend / Share—
ROE-0.9%
Profit Margin-0.3%
Debt / Equity—
Trading
Volume437K
Avg Volume (10D)—
Shares Outstanding52.3M
About Cosmos Health Inc
Cosmos Holdings Inc. is a vertically integrated pharmaceutical company. The company is headquartered in Chicago, Illinois.
HEALTHCAREMEDICAL DISTRIBUTION
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICMEDICAL DISTRIBUTION
CIK—
Composite FIGI—
Share Class FIGI—